发明名称 Antitumors combinations containing antibodies recognizing specifically CD38 and bortezomib
摘要 Pharmaceutical composition comprising an antibody specifically recognizing CD38 and bortezomib.
申请公布号 US9314522(B2) 申请公布日期 2016.04.19
申请号 US201113992684 申请日期 2011.12.08
申请人 Sanofi 发明人 Deckert Jutta;Lejeune Pascale;Mayo Michele;Park Peter U.
分类号 A61K39/395;A61K38/05;C07K16/28 主分类号 A61K39/395
代理机构 Lathrop & Gage LLP 代理人 Lathrop & Gage LLP ;Velema, Esq. James H.
主权项 1. A pharmaceutical combination comprising an antibody specifically recognizing CD38 and at least bortezomib, wherein said antibody comprises at least one heavy chain and at least one light chain, wherein said heavy chain comprises three sequential complementarity determining regions comprising the amino acid sequences of SEQ ID NOs: 13, 14 (or 81) and 15, and wherein said light chain comprises three sequential complementarity determining regions comprising the amino acid sequences of SEQ ID NOs: 16, 17 and 18, and wherein the antibody and bortezomib constituents of the combination are physically separate.
地址 Paris FR